REFRACTORY COLORECTAL CARCINOMA
Clinical trials for REFRACTORY COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for REFRACTORY COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early trial tests new drug combo for Tough-to-Treat cancers
Disease control OngoingThis early-stage study aims to find the safest and most effective dose of a new drug, M6620, when given with the chemotherapy drug irinotecan. It is for adults with advanced solid tumors, like certain colorectal, pancreatic, or lung cancers, that have spread or cannot be removed …
Matched conditions: REFRACTORY COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Blood test aims to personalize cancer care, reduce harsh side effects
Disease control OngoingThis study is testing if a simple blood test can help doctors choose the best treatment for patients with advanced colorectal cancer that has spread. The test looks for tiny pieces of tumor DNA in the blood. Researchers want to see if using this test to guide treatment leads to f…
Matched conditions: REFRACTORY COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC